GlassScriptPhysician profile
Zahid Amin
NPI 1285639435
$634,810.69
in general payments reported to CMS, 2019-2025
14 companies · $46K in 2025
The $46K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156K · 2020: $112K · 2021: $32K · 2022: $64K · 2023: $140K · 2024: $85K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $176K · Travel and Lodging: $46K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $32K · Food and Beverage: $8,460 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,800 · Education: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $175,650.00 |
| Travel and Lodging | $46,252.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,712.50 |
| Food and Beverage | $8,460.32 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,800.00 |
| Education | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $396,921.44 | 2019-2025 | Amplatzer, Amplatzer Piccolo, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $212,909.54 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Philips North America LLC | $10,512.06 | 2019-2024 | (P77) Azurion 7 M20 |
| Medtronic, INC. | $9,172.35 | 2021-2025 | Harmony, Onyx Frontier |
| Occlutech US LLC | $2,250.00 | 2025 | |
| Siemens Medical Solutions USA, INC. | $1,175.41 | 2021-2023 | Acuson Sc2000 Diagnostic Ultrasound System, Diagnostic Ultrasound System |
| W. L. Gore & Associates, INC. | $871.71 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Merit Medical Systems INC | $371.78 | 2024 | |
| B. Braun Interventional Systems INC. | $271.66 | 2022-2023 | Cp Stent |
| Medtronic Vascular, INC. | $124.24 | 2020 | |
| Biolife, L.L.C. | $109.69 | 2025 | |
| Dilon Technologies, INC. | $55.10 | 2023 | Hemoblast Bellows |
| Irhythm Technologies, INC. | $48.13 | 2021-2022 | |
| Viiv Healthcare Company | $17.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zahid Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.